| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = -$66,349 ) |
| | 2027 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA067138 | Pre-Release Medicaid Effects on Youth Experiences Related to Substances (PRiME YEaRS) | 000 | 1 | NIH | 10/15/2026 | $0 |
| | 2027 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H1224845 | Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare | 01 | 14 | HRSA | 10/13/2026 | $0 |
| | 2027 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA066594 | Incorporating real-world patient and clinician preferences in simulating Integrated Models of Prenatal care for Addiction and Hepatitis C Treatment (IMPACT) | 000 | 1 | NIH | 10/30/2026 | $0 |
| | 2027 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33DA059856 | Substance Use Prevention for Recently displaced Adults (SUPRA) | 000 | 3 | NIH | 10/30/2026 | $0 |
| | 2027 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R33DA059856 | Substance Use Prevention for Recently displaced Adults (SUPRA) | 001 | 3 | NIH | 11/2/2026 | $0 |
| | 2027 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R56AI186777 | Mycobacterium tuberculosis disease effect on HIV-1 immunity, evolution, and persistence | 000 | 1 | NIH | 10/21/2026 | -$65,316 |
| | 2027 | 2025 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI167740 | Characterization of HIV-1 IgA bNAbs and ADCP function | 000 | 5 | NIH | 11/12/2026 | $0 |
| | 2027 | 2024 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | ASTWH220118 | Centering(patientswith)Fibroids | 03 | 3 | DHHS/OS | 10/6/2026 | -$1,033 |
| | 2027 | 2023 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | ASTWH220118 | Centering(patientswith)Fibroids | 03 | 3 | DHHS/OS | 10/6/2026 | $0 |
| | 2027 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | ASTWH220118 | Centering(patientswith)Fibroids | 03 | 3 | DHHS/OS | 10/6/2026 | $0 |
|
 | Issue Date FY: 2026 ( Subtotal = $49,032,860 ) (Continued on the next page) |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32AI052074 | BU Clinical HIV/AIDS Research Training Program (BU-CHART) | 002 | 21 | NIH | 9/11/2026 | $473,644 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH138549 | Adaptive interventions to improve posttraumatic stress (PTSD) treatment access, engagement, and effectiveness in routine care | 000 | 2 | NIH | 7/15/2026 | $863,400 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA059908 | Clinical Undergraduate Research in Addictions - Training and Experiences (CURATE) Program | 001 | 2 | NIH | 7/6/2026 | $132,507 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R34DA067031 | Promoting Housing Stability and Preventing Overdose Deaths Among People Recently Housed: Housing plus Overdose Prevention (HOPE) Navigation | 000 | 1 | NIH | 8/21/2026 | $296,460 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK142896 | The Impact of Allostatic Load on Kidney Disease | 000 | 1 | NIH | 7/7/2026 | $918,576 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK146149 | First person storytelling: Improving kidney education for Spanish speakers with advanced kidney disease | 001 | 1 | NIH | 7/15/2026 | $0 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK146149 | First person storytelling: Improving kidney education for Spanish speakers with advanced kidney disease | 000 | 1 | NIH | 1/26/2026 | $194,147 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R03CA308637 | Personalized Spatial Regulatory Networks to Decode Breast Cancer Microenvironments | 000 | 1 | NIH | 6/12/2026 | $178,000 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R13DA064395 | Academic Consortium of Criminal Justice Health | 000 | 2 | NIH | 5/25/2026 | $77,200 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA066594 | Incorporating real-world patient and clinician preferences in simulating Integrated Models of Prenatal care for Addiction and Hepatitis C Treatment (IMPACT) | 000 | 1 | NIH | 9/17/2026 | $847,117 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL178903 | Implementing AI-supported training to scale quality diagnosis and management of heart failure in Rwanda | 002 | 1 | NIH | 9/17/2026 | $13,603 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL178903 | Implementing AI-supported training to scale quality diagnosis and management of heart failure in Rwanda | 001 | 1 | NIH | 9/17/2026 | $186,880 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL178903 | Implementing AI-supported training to scale quality diagnosis and management of heart failure in Rwanda | 000 | 1 | NIH | 9/7/2026 | $646,828 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK149649 | Induced pluripotent stem cell-derived endothelial cell therapy for liver disease | 000 | 1 | NIH | 9/3/2026 | $3,517,102 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T3210028 | NATIONAL RESEARCH SERVICE AWARD | 00 | 29 | HRSA | 9/11/2026 | $489,666 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI186597 | The relationship between HIV exposure, contact networks, and TB in children under 5 years old | 000 | 3 | NIH | 7/22/2026 | $190,512 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK141016 | Role of Intravenous ultrasound (IVUS) in arteriovenous hemodialysis access dysfunction | 000 | 3 | NIH | 8/18/2026 | $759,459 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | U01DK133092 | Boston Chronic Kidney Disease Research Biopsy Center | 000 | 5 | NIH | 7/16/2026 | $799,999 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UT953486 | Supporting Fetal Alcohol Spectrum Disorders (FASD) Screening and Intervention | 00 | 3 | HRSA | 8/6/2026 | $980,553 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | H9E53185 | Transition for Youth with Autism and/or Epilepsy Demonstration Projects | 00 | 3 | HRSA | 7/24/2026 | $449,740 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD115574 | Efficacy of Teleconsultation to Improve Prehospital Patient Safety for Critically Ill Infants and Children - A Multicenter, Simulation-based Randomized Control Trial | 001 | 3 | NIH | 8/20/2026 | $99,517 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD115574 | Efficacy of Teleconsultation to Improve Prehospital Patient Safety for Critically Ill Infants and Children - A Multicenter, Simulation-based Randomized Control Trial | 000 | 3 | NIH | 8/7/2026 | $746,787 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK138309 | Effectiveness Trial to Support Adoption of Hybrid Closed Loop Therapy in Underserved Adults with Type 1 Diabetes: Impact of System Functionality and Features on Lived Experience | 000 | 3 | NIH | 1/28/2026 | $844,525 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32MH135857 | Boston University Medical Campus- Massachusetts General Hospital Global Psychiatric Clinical Research Training Program | 000 | 3 | NIH | 6/23/2026 | $358,488 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 004 | 3 | NIH | 3/4/2026 | $25,758 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 003 | 3 | NIH | 3/3/2026 | $25,758 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 002 | 3 | NIH | 3/2/2026 | $25,758 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 001 | 3 | NIH | 2/27/2026 | $25,758 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NS128342 | Addressing an Inherent Bias in Neuroprognostication: A Collaboration Between the US and Brazil to Reduce the Impact of Self-Fulfilling Prophecy in Cardiac ARrEst (SPARE) | 000 | 3 | NIH | 2/20/2026 | $478,045 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01AI167733 | Nutritional Interventions to End Tuberculosis among Persons with HIV (NUTRIENT) | 000 | 4 | NIH | 9/10/2026 | $128,391 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | NU01DD000016 | Component A; Opioid Use Disorder in Pregnancy and Neonatal Opioid Withdrawal Syndrome Longitudinal Surveillance Project | 00 | 4 | CDC | 8/24/2026 | $499,646 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T2554939 | Addiction Medicine Fellowship | 01 | 2 | HRSA | 6/30/2026 | $0 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T2554939 | Addiction Medicine Fellowship | 00 | 2 | HRSA | 5/21/2026 | $799,517 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | M0154849 | Behavioral Health Workforce Education and Training Program | 00 | 2 | HRSA | 6/4/2026 | $599,853 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA052821 | Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) | 000 | 5 | NIH | 7/10/2026 | $189,216 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DK136973 | Deep learning approach for the assessment of arterial and arteriolar lesions in kidney biopsies and prediction of cardiovascular risk | 000 | 3 | NIH | 8/12/2026 | $151,780 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166606 | Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy | 001 | 3 | NIH | 3/13/2026 | $23,581 |
| | 2026 | 2026 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL166606 | Targeting Energetics to Improve Outcomes in Hypertrophic Cardiomyopathy | 000 | 3 | NIH | 3/9/2026 | $746,783 |
|